Pharmacokinetics and Tolerability of Duloxetine following Oral Administration to Healthy Chinese Subjects

被引：0
|
作者：
Si Tianmei
Mary Pat Knadler
Ming T. Lim
Kwee Poo Yeo
Leyan Teng
Shu Liang
Alan X. Pan
Evelyn D. Lobo
机构：
[1] Peking University Institute of Mental Health,Drug Disposition
[2] Eli Lilly and Company,Lilly
[3] Natlonal University of Singapore,NUS Centre for Clinical Pharmacology
[4] Global Pharmacokinetic/Pharmacodynamic/Trial Simulation,Eli Lilly and Company, Drug Disposition
来源：
Clinical Pharmacokinetics | 2007年 / 46卷
关键词：
Multiple Dose; Duloxetine; CYP1A2 Activity; Intermediate Metabolisers; Japanese Subject;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：767 / 775
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetics and tolerability of duloxetine following oral administration to healthy Chinese subjects
    Tianmei, Si
    Knadler, Mary Pat
    Lim, Ming T.
    Yeo, Kwee Poo
    Teng, Leyan
    Liang, Shu
    Pan, Alan X.
    Lobo, Evelyn D.
    CLINICAL PHARMACOKINETICS, 2007, 46 (09) : 767 - 775
  • [2] Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects
    Xu, Mingzhen
    Ni, Yang
    Zhou, Ying
    He, Xiaomeng
    Li, Huqun
    Chen, Hui
    Li, Weiyong
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) : 541 - 548
  • [3] Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects
    Mingzhen Xu
    Yang Ni
    Ying Zhou
    Xiaomeng He
    Huqun Li
    Hui Chen
    Weiyong Li
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 541 - 548
  • [4] Pharmacokinetics of vorapaxar and its metabolite following oral administration in healthy Chinese and American subjects
    Chen, Xia
    Kosoglou, Teddy
    Statkevich, Paul
    Kumar, Bharath
    Li, Jing
    Dockendorf, Marissa F.
    Wang, Guoqin
    Lowe, Robert S.
    Jiang, Ji
    Liu, Hongzhong
    Wang, Zaiqi
    Cutler, David L.
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (10) : 889 - 899
  • [5] Pharmacokinetics of rabeprazole following single intravenous and oral administration to healthy subjects
    Setoyama, T
    Laurent, A
    Humphries, T
    Hasegawa, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (01) : 37 - 42
  • [6] Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration
    Farre, M
    Roset, PN
    Llorente, M
    Marquez, M
    Albet, C
    Perez, JA
    Herrero, E
    Ortiz, JA
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1997, 19 (05): : 343 - 350
  • [7] A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects
    Yang, Haijing
    Jin, Yi
    Wang, Hailin
    Yuan, Hong
    Wang, Jingjing
    Li, Size
    Hu, Yingying
    Yang, Huahui
    Li, Xin
    Liang, Hong
    Wu, Jufang
    Cao, Guoying
    Zhang, Jing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (11)
  • [8] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF LEMBOREXANT IN HEALTHY CHINESE SUBJECTS
    Moline, M.
    Nakai, K.
    Morita, M.
    Zhao, T.
    Takese, T.
    Cheng, J. Y.
    Yun, L.
    SLEEP MEDICINE, 2022, 100 : S132 - S133
  • [9] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects
    Yong Ha Chi
    Howard Lee
    Soo Heui Paik
    Joo Han Lee
    Byoung Wook Yoo
    Ji Han Kim
    Hyun Kwang Tan
    Sang Lin Kim
    American Journal of Cardiovascular Drugs, 2011, 11 : 335 - 346
  • [10] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects
    Chi, Yong Ha
    Lee, Howard
    Paik, Soo Heui
    Lee, Joo Han
    Yoo, Byoung Wook
    Kim, Ji Han
    Tan, Hyun Kwang
    Kim, Sang Lin
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (05) : 335 - 346
12345